Kazuhiko Yoshida

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 19

Top Topics

Combination Therapy

Tyrosine Kinase

Editorial Comment

Top Venues

Japanese journal of clinical oncology

International journal of urology : official journal of the Japanese Urological Association

International journal of clinical oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Hiroki Ishihara, Nemoto Yuki, Ryo Ishiyama, Takashi Ikeda, Yuki Kobari, Hironori Fukuda, Kazuhiko Yoshida, Hiroaki Shimmura, Yasunobu Hashimoto, Junpei Iizuka, Tsunenori Kondo, Toshio Takagi
Real-world outcomes of nivolumab plus ipilimumab combination therapy for advanced renal cell carcinoma in Japanese patients: data with a minimum of 3 years of follow-up. Japanese journal of clinical oncology (2024)
Kazuhiko Yoshida, Naoki Nagasaka, Tsunenori Kondo, Yuki Kobari, Hiroki Ishihara, Hironori Fukuda, Junpei Iizuka, Hideki Ishida, Toshio Takagi
Comparative analysis of dual immune checkpoint inhibitor combination therapy versus immune checkpoint inhibitor plus tyrosine kinase inhibitor combination therapy for renal cell carcinoma with inferior vena cava tumor thrombosis. International journal of clinical oncology (2024)
Hiroki Ishihara, Nemoto Yuki, Ryo Ishiyama, Takashi Ikeda, Yuki Kobari, Hironori Fukuda, Kazuhiko Yoshida, Hiroaki Shimmura, Yasunobu Hashimoto, Junpei Iizuka, Tsunenori Kondo, Toshio Takagi
Real-world outcomes of nivolumab plus ipilimumab combination therapy for advanced renal cell carcinoma in Japanese patients: data with a minimum of 3 years of follow-up. Japanese journal of clinical oncology 54 (5) (2024)
Hiroki Ishihara, Nemoto Yuki, Ryo Ishiyama, Takashi Ikeda, Yuki Kobari, Hironori Fukuda, Kazuhiko Yoshida, Hiroaki Shimmura, Yasunobu Hashimoto, Junpei Iizuka, Tsunenori Kondo, Toshio Takagi
Real-world outcomes of nivolumab plus ipilimumab combination therapy for advanced renal cell carcinoma in Japanese patients: data with a minimum of 3 years of follow-up. Japanese journal of clinical oncology 54 (5) (2024)
Hiroki Ishihara, Nemoto Yuki, Ryo Ishiyama, Takashi Ikeda, Yuki Kobari, Hironori Fukuda, Kazuhiko Yoshida, Hiroaki Shimmura, Yasunobu Hashimoto, Junpei Iizuka, Tsunenori Kondo, Toshio Takagi
Real-world outcomes of nivolumab plus ipilimumab combination therapy for advanced renal cell carcinoma in Japanese patients: data with a minimum of 3 years of follow-up. Japanese journal of clinical oncology 54 (5) (2024)
Kazuhiko Yoshida, Nao Oida, Tsunenori Kondo, Yuki Kobari, Hiroki Ishihara, Hironori Fukuda, Junpei Iizuka, Hirohito Kobayashi, Hideki Ishida, Toshio Takagi
Surgical and functional outcomes of repeat robot-assisted laparoscopic partial nephrectomy compared with repeat open partial nephrectomy. International journal of urology : official journal of the Japanese Urological Association 31 (4) (2023)
Hiroki Ishihara, Takashi Ikeda, Hironori Fukuda, Kazuhiko Yoshida, Hirohito Kobayashi, Junpei Iizuka, Yoji Nagashima, Tsunenori Kondo, Toshio Takagi
Renal cell carcinoma outcomes in end-stage renal disease: A 40-year study from two Japanese institutions. International journal of urology : official journal of the Japanese Urological Association (2023)
Hiroki Ishihara, Yuki Nemoto, Hidekazu Tachibana, Hironori Fukuda, Kazuhiko Yoshida, Hirohito Kobayashi, Junpei Iizuka, Yasunobu Hashimoto, Tsunenori Kondo, Toshio Takagi
Real-world efficacy and safety of cabozantinib following immune checkpoint inhibitor failure in Japanese patients with advanced renal cell carcinoma. Japanese journal of clinical oncology (2023)
Kazuhiko Yoshida, Nao Oida, Tsunenori Kondo, Yuki Kobari, Hiroki Ishihara, Hironori Fukuda, Junpei Iizuka, Hirohito Kobayashi, Hideki Ishida, Toshio Takagi
Surgical and functional outcomes of repeat robot-assisted laparoscopic partial nephrectomy compared with repeat open partial nephrectomy. International journal of urology : official journal of the Japanese Urological Association 31 (4) (2023)
Kazuhiko Yoshida, Nao Oida, Tsunenori Kondo, Yuki Kobari, Hiroki Ishihara, Hironori Fukuda, Junpei Iizuka, Hirohito Kobayashi, Hideki Ishida, Toshio Takagi
Surgical and functional outcomes of repeat robot-assisted laparoscopic partial nephrectomy compared with repeat open partial nephrectomy. International journal of urology : official journal of the Japanese Urological Association (2023)
Arisa Wada, Kenji Omae, Kazuhiko Yoshida, Tsunenori Kondo, Kazunari Tanabe, Toshio Takagi
Comparison of surgical outcomes after robot-assisted laparoscopic partial nephrectomy between patients continuing and discontinuing aspirin therapy: a Japanese single-centre study. Japanese journal of clinical oncology 52 (5) (2022)
Kazuhiko Yoshida, Tsunenori Kondo, Junpei Iizuka, Hironori Fukuda, Hiroki Ishihara, Hirohito Kobayashi, Masayoshi Okumi, Hideki Ishida, Kazunari Tanabe, Toshio Takagi
Surgical and functional outcomes of robot-assisted laparoscopic partial nephrectomy for renal cell carcinoma in adolescents and young adults: a propensity score matching study. International journal of clinical oncology 27 (10) (2022)
Hiroki Ishihara, Yuki Nemoto, Hidekazu Tachibana, Hironori Fukuda, Kazuhiko Yoshida, Hirohito Kobayashi, Junpei Iizuka, Yasunobu Hashimoto, Toshio Takagi, Hideki Ishida, Tsunenori Kondo, Kazunari Tanabe
Outcomes of nivolumab monotherapy for previously treated metastatic renal cell carcinoma: a real-world multi-institution data with a minimum of 2 years of follow-up. Japanese journal of clinical oncology 52 (7) (2022)
Hiroki Ishihara, Hironori Fukuda, Kazuhiko Yoshida, Yasunobu Hashimoto, Tsunenori Kondo, Toshio Takagi
Continuation of immune checkpoint inhibitors for newly developed brain metastasis during immune checkpoint inhibitor treatment for oligoprogressive metastatic renal cell carcinoma. International journal of urology : official journal of the Japanese Urological Association (2022)
Kazuhiko Yoshida, Yuki Kobari, Junpei Iizuka, Tsunenori Kondo, Hideki Ishida, Kazunari Tanabe, Toshio Takagi
Robot-assisted laparoscopic versus open partial nephrectomy for renal cell carcinoma in patients with severe chronic kidney disease. International journal of urology : official journal of the Japanese Urological Association 29 (11) (2022)
Maki Yoshino, Hiroki Ishihara, Yuki Nemoto, Kazutaka Nakamura, Koichi Nishimura, Hidekazu Tachibana, Hironori Fukuda, Daisuke Toki, Kazuhiko Yoshida, Hirohito Kobayashi, Junpei Iizuka, Hiroaki Shimmura, Yasunobu Hashimoto, Kazunari Tanabe, Tsunenori Kondo, Toshio Takagi
Therapeutic role of deferred cytoreductive nephrectomy in patients with metastatic renal cell carcinoma treated with nivolumab plus ipilimumab. Japanese journal of clinical oncology 52 (10) (2022)
Yudai Ishiyama, Tsunenori Kondo, Kazuhiko Yoshida, Junpei Iizuka, Kazunari Tanabe, Toshio Takagi
"Thrombus-first" or "thrombus-last" approach for surgical management of renal cell carcinoma with inferior vena cava thrombus. International journal of urology : official journal of the Japanese Urological Association 29 (6) (2022)
Toshio Takagi, Kazuhiko Yoshida, Hironori Fukuda, Yuki Kobari, Junpei Iizuka
Analyses of operative time according to procedure phases during robot-assisted laparoscopic partial nephrectomy using the iPhone application "My Intuitives". International journal of urology : official journal of the Japanese Urological Association 29 (11) (2022)
Hiroki Ishihara, Tsunenori Kondo, Kazutaka Nakamura, Yuki Nemoto, Hidekazu Tachibana, Hironori Fukuda, Kazuhiko Yoshida, Hirohito Kobayashi, Junpei Iizuka, Hiroaki Shimmura, Yasunobu Hashimoto, Kazunari Tanabe, Toshio Takagi
Association of tumor burden with outcome in first-line therapy with nivolumab plus ipilimumab for previously untreated metastatic renal cell carcinoma. Japanese journal of clinical oncology 51 (12) (2021)